Veradermics (MANE), a hair loss therapy developer, files for a U.S. IPO, targeting up to $534M valuation and $182M in net proceeds. Read more here.

Something’s been amiss when I wash my hair. Instead of the odd few strands escaping — totally normal, by the way — my hands ...

A centuries-old medicinal root is gaining renewed scientific attention for its ability to target multiple biological processes involved in hair loss. Androgenetic alopecia (AGA) is the most common ...

A popular over-the-counter supplement that patients with cancer are prescribed or buy on their own to improve hair and nail ...

All dosing regimens of topical GT20029 among men with androgenetic alopecia had significant improvements in growth of target area non-vellus hair count at 12 weeks of treatment compared with placebo.

Hair loss often begins with the widening of your part line, or a patch of hair that’s looking a bit thinner than it used to be.